SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-027467
Filing Date
2021-11-29
Accepted
2021-11-29 15:24:24
Documents
13
Period of Report
2021-11-29
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K inbp20211129_8k.htm   iXBRL 8-K 51897
  Complete submission text file 0001437749-21-027467.txt   173891

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA inbp-20211129.xsd EX-101.SCH 3594
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20211129_def.xml EX-101.DEF 10354
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20211129_lab.xml EX-101.LAB 13837
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20211129_pre.xml EX-101.PRE 10349
6 EXTRACTED XBRL INSTANCE DOCUMENT inbp20211129_8k_htm.xml XML 2312
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31668 | Film No.: 211455875
SIC: 2834 Pharmaceutical Preparations